Shares of Centene Co. (NYSE:CNC) have earned an average recommendation of “Buy” from the nineteen analysts that are currently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and fifteen have issued a buy recommendation on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $112.93.
Several equities analysts have recently weighed in on the stock. Morgan Stanley lifted their target price on shares of Centene from $126.00 to $127.00 and gave the company an “overweight” rating in a report on Wednesday, April 25th. Zacks Investment Research lowered shares of Centene from a “strong-buy” rating to a “hold” rating in a report on Tuesday, April 10th. ValuEngine raised shares of Centene from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. Cantor Fitzgerald lifted their target price on shares of Centene from $115.00 to $125.00 and gave the company an “overweight” rating in a report on Wednesday, February 7th. Finally, Credit Suisse Group lifted their target price on shares of Centene from $110.00 to $112.00 and gave the company a “neutral” rating in a report on Wednesday, February 7th.
In other Centene news, Director Robert K. Ditmore sold 8,750 shares of Centene stock in a transaction on Thursday, April 26th. The shares were sold at an average price of $108.15, for a total transaction of $946,312.50. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, EVP Christopher D. Bowers sold 4,800 shares of Centene stock in a transaction on Monday, March 12th. The stock was sold at an average price of $102.27, for a total transaction of $490,896.00. The disclosure for this sale can be found here. In the last three months, insiders sold 265,550 shares of company stock valued at $28,712,209. 3.00% of the stock is owned by insiders.
Centene opened at $115.38 on Friday, MarketBeat reports. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.68. The company has a market cap of $23.67 billion, a PE ratio of 22.94, a PEG ratio of 1.11 and a beta of 0.75. Centene has a 1-year low of $72.14 and a 1-year high of $117.86.
Centene (NYSE:CNC) last posted its earnings results on Tuesday, April 24th. The company reported $2.17 earnings per share for the quarter, beating the consensus estimate of $1.92 by $0.25. The firm had revenue of $13.19 billion during the quarter, compared to analyst estimates of $13.33 billion. Centene had a net margin of 2.06% and a return on equity of 15.69%. The business’s quarterly revenue was up 12.5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.12 EPS. analysts expect that Centene will post 7.05 earnings per share for the current fiscal year.
Centene Company Profile
Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates through two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term care, foster care, and dual eligible individual, as well as aged, blind, or disabled programs.
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.